Kiyotaka Miura

Nephrotoxicity Induced by Piperacillin–Tazobactam in Late Elderly Japanese Patients with Nursing and Healthcare Associated Pneumonia

Fumi Karino, Nobuhiro Nishimura, Noriyuki Ishihara et al. · Biological and Pharmaceutical Bulletin · 2014 · 23 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Comparison of the chest computed tomography findings between patients with pulmonary tuberculosis and those with Mycobacterium avium complex lung disease

Kiyotaka Miura, Megumi Nakamura, Yasuyuki Taooka et al. · Respiratory Investigation · 2020 · 21 citations

Medicine, Infectious Diseases, Radiology +14

Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumonia

Fumi Karino, Kiyotaka Miura, Hiroshi Fuchita et al. · Journal of Infection and Chemotherapy · 2013 · 18 citations

Pharmacy, Geriatric Medicine, Pharmacotherapy +16

Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)

Yukari Tsubata, Kana Watanabe, Ryota Saito et al. · International Journal of Clinical Oncology · 2021 · 17 citations · Full text

Medicine, Oncology, Pharmacology +16

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia

Noriyuki Ishihara, Nobuhiro Nishimura, Kazuro Ikawa et al. · Antibiotics · 2020 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17